Filter by:

Type

News

PharmaKure win: MHRA Grants Clinical Trial Authorisation

...first dose.” About Alzheimer’s Disease Alzheimer’s disease is a fatal illness causing a progressive decline in memory and cognition. It accounts for 60 to 80 percent of all dementia cases,...

News

GreenBank Capital’s Intent to Acquire Alzheimer’s Treatment Innovator: Pharmakure

...treatment for Alzheimer’s. Alzheimer’s Disease affects the brain – causing loss in memory and bodily functions, ultimately leading to death. Despite the enormous human and financial cost of Alzheimer’s Disease...

Projects + Tech

PharmaKure: Precision Medicines for Alzheimer’s and Parkinson’s Disease

...other neurodegenerative disorders. A Growing Crisis: Alzheimer’s and Parkinson’s Disease Alzheimer’s and Parkinson’s diseases have reached alarming levels, affecting millions of individuals worldwide. These conditions not only rob individuals of...

News

PharmaKure Submits MHRA Clinical Trial Application

PharmaKure submits MHRA CTA for Phase 2a Clinical Trial of PK051 in patients with mild cognitive impairment In a significant stride toward combatting Alzheimer’s Disease, PharmaKure, a clinical stage pharmaceutical...

Projects + Tech

Biotech brilliance - StrataStem Ltd

StrataStem Ltd is a spinout biotechnology company seeking to transform the diagnosis and treatment of Alzheimer’s disease StrataStem is developing innovative drug screening platforms to identify appropriate therapeutics for Alzheimer’s...

Projects + Tech

MPSIIIC Gene therapy for lysosomal storage disease

This project is license-ready Designed to address Mucopolysaccharidosis IIIC, this innovation presents a transformative solution for lysosomal storage diseases, spearheading advancements in genetic therapy The disease Mucopolysaccharidosis IIIC (MPSIIIC) stems...

News

Promising novel treatment for Dry Eye Disease revealed by new research

The University of Manchester, Seoul National University College of Medicine and Link Biologics Limited today announced that promising preclinical data on the treatment of Dry Eye Disease using a novel...

Projects + Tech

The cellular level – eNAMPT stimulation

...pathophysiology of a range of chronic inflammatory diseases, such as diabetes, cardiovascular disease, Alzheimer’s disease, and osteo and rheumatoid arthritis, where there is an emerging relationship between eNAMPT levels and...

News

Link Biologics and Théa Open Innovation enter partnership to develop Link_TSG6 for Dry Eye Disease

...been shown to have potent disease modifying properties in various preclinical models, including models of Dry Eye Disease. Comparison illustration between normal and dry eye. Cross section of eye surface....

News

Music in Mind Remote launches UK first centre of excellence

...direct musical support activities across all of Greater Manchester’s 10 boroughs, starting in October 2024. Music in Mind sees the Camerata work with Alzheimer’s Society and the University of Manchester...

Projects + Tech

The Future of Farming

...food output, and as such researchers are searching for solutions to consistently increase crop yields. Their first product, a device that scans plants to detect disease, used by plant breeders....

News

University announces partnership with AVROBIO for Hunter syndrome gene therapy

...worldwide license and collaborative research funding agreement with AVROBIO, Inc., a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, based in...

Projects + Tech

Rapid diagnosis for Parkinson’s - SebOMIX Ltd

A non-invasive test for Parkinson’s Disease, potentially offering rapid, non-invasive diagnosis before the onset of symptoms Parkinson’s Disease is an age-related degenerative neurological disorder characterised by shaking, stiffness, and difficulty...

Projects + Tech

Super MAN stem cells - Ethical stem cells

...a range of degenerative diseases. Cost-effective treatment that is affordable by public health systems will only be possible if allogenic tissue banks are stocked with high quality clinical grade hESC’s....

Projects + Tech

In the genes - Gene-cell therapies

...enabling platform technology will be applicable to the correction of many rare genetic diseases affecting the mesoderm. Disease-specific therapeutic cells are derived by genetic modification of the immune privileged cells...

Projects + Tech

Spotting cell senescence - SenTraGor

...Evidence is pointing to a crucial role in ageing, cancer, cardiovascular diseases and neuro-degeneration amongst many indications. Detecting cell senescence is becoming crucial in understanding disease pathology. Current methodologies for...

Projects + Tech

Identifying Genetic Biomarkers

GeneGini enables Academic and Pharmaceutical Researchers to prognose, diagnose and sub-categorise more diseases with better accuracy and sensitivity. Researchers of genetic diseases have a limited choice of genetic biomarkers to...

News

VREvo wins Top Tech North West recognition

...text to voice functionality. It will cover basic eye physiology as well as introduce students to common eye diseases such as age-related macular degeneration and glaucoma, with approximately 1 hour...

News

Record Year for The University of Manchester Innovation Factory

...anti-fungal therapeutics with an initial focus on the eye disease fungal keratitis Gene Gini Ltd – Reference gene software Mantra Diagnostics Ltd – Hypoxic Tumour Biomarkers to support targeted treatment...

News

Brain implant firm wins £12m funding with Graphene@Manchester nanotech

A collaboration between two Barcelona institutions and the Nanomedicine Lab at The University of Manchester – aimed at treating brain disorders such as epilepsy and Parkinson’s Disease – has secured...

News

Complement Therapeutics Secures €72 Million in Series A Financing

Complement Therapeutics GmbH (CTx), a preclinical stage biotechnology company developing novel therapeutics for complement mediated diseases, today announced the completion of a €72m Series A financing to further develop its...

Projects + Tech

The missing link - Link Biologics

...diseases. Our initial focus is on dry eye disease (DED) and osteoarthritis (OA), conditions for which there are currently inadequate treatment options. Our work in pre-clinical models has shown that...

Projects + Tech

One-pot enzymatic manufacturing of therapeutic oligonucleotides

...therapeutics (NATs) are crucial for selectively modulating the production of disease-related proteins. However, existing chemical synthesis methods are not conducive to large-scale applications, presenting several challenges: Solid supports and chemical...

News

British start-up concludes £130,000 crowdfunding raise to develop smart tech to help the UK’s 5.4m asthma sufferers

...us to move forward with the scale-up of our existing Rafi-Tone smartphone app, and to commercialise our new Clip-Tone app technology to help adults with asthma and other respiratory diseases....

News

Michelson Diagnostics teams up with AI Specialists Manchester Imaging to develop Machine Learning Algorithms for VivoSight OCT Skin Imaging System

...skin cancer and other skin diseases. Michelson’s VivoSight™ Dx OCT scanner is used by trained dermatologists in their assessment of suspicious skin lesions, and is already in widespread routine use...

News

MHRA awards Complement Therapeutics Innovation Passport for CTx001 to accelerate Gene Therapy for Geographic Atrophy

...(CTx), a biotechnology company developing novel therapeutics for complement-related diseases, today announced its lead asset CTx001, an AAV-based gene therapy for the treatment of Geographic Atrophy (GA), has been awarded...

News

Another Impressive Financial Year for Manchester-Born Spinouts

...Apini Therapeutics Ltd– Novel Small Molecule Therapeutics for the treatment of inflammatory diseases without induction of immune suppression Holiferm Ltd – Fermentation technology with initial focus on biosurfactants Imperagen Ltd...

News

Recruitment underway for significant asthma technology study at University of Manchester

...role that technology can play in respiratory disease management.” The study is aiming to build upon existing findings that Clin-e-cal’s Clip-Tone Buddy technology can effectively provide real-time feedback in inhaler...

Page

Empowerment Scale

...adolescents and parents in underserved populations Belgium, Sweden and Denmark: adolescents with congenital heart disease China: elderly patients with long-term conditions We request that where you use the Empowerment Scale,...

Projects + Tech

AbBind: A novel virus-like particle platform

...multimeric complexes called virus-like particles (VLPs). These can act as scaffolds to display heterologous antigens in infectious disease and cancer vaccines. Previously, antigens of interest have been directly fused to...

News

World IP Day: Women and IP

...A non-invasive test for Parkinson’s Disease, potentially offering rapid, non-invasive diagnosis before the onset of symptoms Professor Perdita Barran, Founder of SebOMIX   CareLoop Digital therapeutics (DTx) for severe mental...

News

Clin-e-cal launches crowdfunding campaign

...inhaler technique and respiratory disease outcomes.” Clin-e-cal’s Rafi-Tone app is featured in the NHS app library, and studies have found the app has had a marked positive effect on the...

Projects + Tech

InPepCide - Fungal keratitis treatment

This new technology can be the quick and accurate intervention needed to prevent vision loss Fungal keratitis or fungal corneal infections is a world-wide disease, with a higher incidence in...

News

Scientists move closer to developing ‘game-changing’ test to diagnose Parkinson’s

...compounds found in sebum – the oily substance that coats and protects the skin – and identifying changes in people with Parkinson’s Disease. Sebum is rich in lipid-like molecules and...

Projects + Tech

A vision of success - Complement Therapeutics Ltd

Taking on two devastating immune system diseases, AMD and GA, Complement Therapeutics Ltd is developing new strategies to enhance one of the most promising areas in patient care The complement...

News

TaBrix joins forces with TB Alliance

...1.5m die of the disease. One of the main obstacles in the eradication of TB is antibiotic resistance, and there are roughly 500,000 new cases of drug-resistant TB per year....

No results found.

Tips: use keywords instead of phrases.
Try searching a subject instead of a specific project